CHRS

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Coherus BioSciences (CHRS) Earnings Date & Reports

Industry: @Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

CHRS is expected to report earnings to rise 2,947.00% to -30 cents per share on February 27

Coherus BioSciences CHRS Stock Earnings Reports

Q4'24

Est.

$-0.30

Q3'24

Beat

by $0.15

Q2'24

Beat

by $0.11

Q1'24

Missed

by $0.07

Q4'23

Missed

by $0.41

The last earnings report on November 06 showed earnings per share of 0 cents, beating the estimate of -15 cents. With 1.14M shares outstanding, the current market capitalization sits at 197.01M.

View a ticker or compare two or three

Compare

CHRS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For CHRS
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a maker of biologic therapeutics for oncology and inflammatory diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

333 Twin Dolphin Drive

Phone

+1 650 649-3530

Employees

306

Web

https://www.coherus.com